These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23857000)

  • 1. Release of soluble CD30 after allogeneic stimulation is mediated by memory T cells and regulated by IFN-γ and IL-2.
    Velásquez SY; García LF; Opelz G; Alvarez CM; Süsal C
    Transplantation; 2013 Jul; 96(2):154-61. PubMed ID: 23857000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CD30 transcripts with Th1 responses and proinflammatory cytokines in patients with end-stage renal disease.
    Velásquez SY; Opelz G; Rojas M; Süsal C; Alvarez CM
    Hum Immunol; 2016 May; 77(5):403-10. PubMed ID: 26970513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased bone marrow (BM) plasma level of soluble CD30 and correlations with BM plasma level of interferon (IFN)-γ, CD4/CD8 T-cell ratio and disease severity in aplastic anemia.
    Wu Q; Zhang J; Shi J; Ge M; Li X; Shao Y; Yao J; Zheng Y
    PLoS One; 2014; 9(11):e110787. PubMed ID: 25383872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral T lymphocyte cytokine profile (IFNgamma, IL-2, IL-4) and CD30 expression/release during measles infection.
    Vinante F; Krampera M; Morosato L; Rigo A; Romagnani S; Pizzolo G
    Haematologica; 1999 Aug; 84(8):683-9. PubMed ID: 10457402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro.
    Eichenauer DA; Simhadri VL; von Strandmann EP; Ludwig A; Matthews V; Reiners KS; von Tresckow B; Saftig P; Rose-John S; Engert A; Hansen HP
    Cancer Res; 2007 Jan; 67(1):332-8. PubMed ID: 17210715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
    Solgi G; Amirzagar AA; Pourmand G; Mehrsai AR; Taherimahmoudi M; Baradaran N; Nicknam MH; Ebrahimi Rad MR; Saraji A; Asadpoor AA; Moheiydin M; Nikbin B
    Transplant Proc; 2009 Sep; 41(7):2800-4. PubMed ID: 19765439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy.
    Sadeghi M; Süsal C; Daniel V; Naujokat C; Zimmermann R; Huth-Kühne A; Opelz G
    AIDS Res Hum Retroviruses; 2007 Jul; 23(7):886-90. PubMed ID: 17678471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloantigen-stimulated induction and release of CD30 in patients with end-stage renal failure.
    Velásquez SY; Süsal C; Opelz G; García LF; Alvarez CM
    Hum Immunol; 2012 Nov; 73(11):1102-8. PubMed ID: 22940451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
    Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte membrane antigen expression and intracellular cytokine patterns in an asymptomatic patient with persistently high serum levels of IgE.
    Krampera M; Antico A; Vinante F; Morosato L; Pizzolo G
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):144-8. PubMed ID: 10480588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological functions of CD30+ CD4+ T cells in rheumatoid arthritis.
    Okamoto A; Yamamura M; Iwahashi M; Aita T; Ueno A; Kawashima M; Yamana J; Kagawa H; Makino H
    Acta Med Okayama; 2003 Dec; 57(6):267-77. PubMed ID: 14726963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular IL-4, IL-5, and IFN-γ as the main characteristic of CD4+CD30+ T cells after allergen stimulation in patients with vernal keratoconjunctivitis.
    Magaña D; Aguilar G; Linares M; Ayala-Balboa J; Santacruz C; Chávez R; Estrada-Parra S; Garfias Y; Lascurain R; Jiménez-Martínez MC
    Mol Vis; 2015; 21():443-50. PubMed ID: 25999672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of CD30 and CD57 molecules on CD4(+) T cells from children with atopic asthma: a preliminary report.
    Rojas-Ramos E; Garfias Y; Jiménez-Martínez Mdel C; Martínez-Jiménez N; Zenteno E; Gorocica P; Lascurain R
    Allergy Asthma Proc; 2007; 28(6):659-66. PubMed ID: 18201430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes.
    Ebsen H; Lettau M; Kabelitz D; Janssen O
    Mol Immunol; 2015 Jun; 65(2):416-28. PubMed ID: 25745808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
    van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
    J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection.
    Manetti R; Annunziato F; Biagiotti R; Giudizi MG; Piccinni MP; Giannarini L; Sampognaro S; Parronchi P; Vinante F; Pizzolo G; Maggi E; Romagnani S
    J Exp Med; 1994 Dec; 180(6):2407-11. PubMed ID: 7964515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
    Cabrera CM; Urra JM; Carreño A; Zamorano J
    Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-15 controls T cell functions through its influence on CD30 and OX40 antigens in Celiac Disease.
    Periolo N; Guillén L; Arruvito ML; Alegre NS; Niveloni SI; Hwang JH; Bai JC; Cherñavsky AC
    Cytokine; 2014 May; 67(1):44-51. PubMed ID: 24680481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines.
    Del Prete G; De Carli M; Almerigogna F; Daniel CK; D'Elios MM; Zancuoghi G; Vinante F; Pizzolo G; Romagnani S
    FASEB J; 1995 Jan; 9(1):81-6. PubMed ID: 7821763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.